Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib and Radiotherapy in Soft Tissue Sarcoma
NCT02575066Phase 2Terminated
- Sponsor
- Netherlands Cancer Institute
- Start
- Mar 2016
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pazopanib in soft tissue sarcoma (STS), sponsored by Netherlands Cancer Institute. Started Mar 2016; status: terminated.
02
Drugs
pazopanib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT02575066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02575066.